Concepedia

William Seger

WS

3

Publications

219

Citations

3

H-Index

2022

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Meridian Clinical Research

Benchmark Research (United States)

William Seger is an author at Moderna Therapeutics (United States) specializing in vaccine safety, vaccination, and medicine.

Top concepts

Publications per year

2022–2023

3

Publications

3

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Brandon Essink, Laurence Chu, William Seger et al. · The Lancet Infectious Diseases · 2023 · 129 citations

, , +8

Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults

Allison August, Christine A. Shaw, Heather Lee et al. · Open Forum Infectious Diseases · 2022 · 77 citations · Full text

Risk of COVID-19 after natural infection or vaccination

Anne-Marie Rick, Matthew B. Laurens, Ying Huang et al. · EBioMedicine · 2023 · 13 citations · Full text

Rows per page

1–3 of 3